Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (121 ops.)
Latest filing published 03 Mar 2025 for PFIZER INC, €54k.
Filing timeline
BuySaleSally Susman
Insider track record
Disclosed buys
1
Disclosed sells
121
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +56.8%Entry US$33.85 · Close at T+365 US$53.09
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Sally Susman: trading record in brief
Sally Susman, Executive Vice President at Pfizer Inc, filed 188 of the 189 filings of the record at that company, including 121 sales worth EUR 14.1 million with a median of EUR 35,595. Each sale is modest; the volume comes from the count. The largest date from November 9, 2020 (EUR 1,539,715), May 9, 2016 (EUR 1,171,395) and November 26, 2021 (EUR 996,562).
The other filing is a purchase of EUR 94,138, on April 16, 2024, at UL Solutions Inc., where the role is Director. It makes up 1% of the open-market trades. The record also holds 45 grants, 20 option exercises and 2 filings of another kind.
The year 2019 counts 68 filings, ahead of 2016 and 2018 (31 each), while 2021 counts only one. The latest trade in the record is dated February 27, 2025. Filings are published a median of 2 days after the trade. Susman has 101, 100 and 93 own market trades within 30 days of colleagues at Pfizer Inc, in that order, all in the same direction. The colleagues, in the same order: Ian C. Read, Mikael Dolsten and Alexander R. Mackenzie.
Companies and markets linked to Sally Susman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations189 total
2,178 shares@ US$26.100.1% of flowCommon StockSEC:0001225208-25-002708:1
79,779 shares@ US$26.062.3% of flowCommon StockSEC:0001225208-25-002708:2
85,182 shares@ US$31.3119.5% of flowCommon StockSEC:0001225208-25-002708:0
2,785 shares@ US$26.300.1% of flowCommon StockSEC:0001225208-25-002399:1
56,715 shares@ US$26.081.6% of flowCommon StockSEC:0001225208-25-002399:2
63,573 shares@ US$30.1714.0% of flowCommon StockSEC:0001225208-25-002399:0
3,571 shares@ US$28.00100.0% of flowClass A Common StockSEC:0001628280-24-016771:0
Canonical exit: 15 Jul 2024 (T+90)
4,948 shares@ US$27.760.1% of flowCommon StockSEC:0001225208-24-003055:1
51,589 shares@ US$27.371.5% of flowCommon StockSEC:0001225208-24-003055:2
63,837 shares@ US$27.3412.4% of flowCommon StockSEC:0001225208-24-003055:0
22,413 shares@ US$41.751.0% of flowCommon StockSEC:0001225208-23-002985:1
32,455 shares@ US$43.441.5% of flowCommon StockSEC:0001225208-23-002985:2
72,984 shares@ US$22.8912.1% of flowCommon StockSEC:0001225208-23-002985:0
13,007 shares@ US$42.380.6% of flowCommon StockSEC:0001225208-23-002831:1
46,291 shares@ US$43.702.2% of flowCommon StockSEC:0001225208-23-002831:2
76,043 shares@ US$30.1716.5% of flowCommon StockSEC:0001225208-23-002831:0
5,000 shares0Common StockSEC:0001225208-22-006908:0
18,745 shares@ US$47.720.9% of flowCommon StockSEC:0001225208-22-003724:1
29,685 shares@ US$50.641.5% of flowCommon StockSEC:0001225208-22-003724:2
63,580 shares@ US$25.6011.2% of flowCommon StockSEC:0001225208-22-003724:0
19,110 shares@ US$46.870.9% of flowCommon StockSEC:0001225208-22-003472:1
38,060 shares@ US$51.282.0% of flowCommon StockSEC:0001225208-22-003472:2
76,895 shares@ US$27.3414.2% of flowCommon StockSEC:0001225208-22-003472:0
101 shares@ US$54.480.0% of flowCommon StockSEC:0001225208-21-014219:1
250 shares@ US$54.570.0% of flowCommon StockSEC:0001225208-21-014219:2
25 of 189 declarations
